An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

The use of TNF inhibitors was not linked to worse survival outcomes among patients with rheumatoid arthritis during the 3 years after being diagnosed with lung, colorectal, or prostate cancer.

announced that data from the Phase 2a clinical trial of its oral TNF-alpha (TNF-α) inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th ...

[20] The current indication in the USA for this newly approved therapy is for active RA patients who have failed at least one TNF inhibitor. It is a monthly infusion, lasting approximately 1 h ...

Tumor necrosis factor alpha (TNF α) is involved in cell differentiation, mitogenesis, cytotoxic responses, inflammation, immunomodulation, and wound healing. Because of its numerous roles ...

As with other drugs, Remicade (infliximab) can cause side effects, such as infusion reactions. If you are not able to tolerate side effects of Remicade, talk with your doctor or pharmacist.